Hrt Financial LP Enanta Pharmaceuticals Inc Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$11.09 - $22.13 $1.14 Million - $2.27 Million	102,698 New	102,698 $1.15 Million
Q1 2023 May 12, 2023	BUY	$38.82 - $54.59 $404,698 - $569,100	10,425 New	10,425 $421,000
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $901,719 - $1.33 Million	18,673 New	18,673 $968,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $352,897 - $466,522	-6,295 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $19,862 - $32,132	330 Added 5.53%	6,295 $470,000
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $404,662 - $578,582	-9,865 Reduced 62.32%	5,965 $338,000
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $692,720 - $840,731	15,830 New	15,830 $696,000
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $216,675 - $249,054	-3,739 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $224,639 - $329,667	3,739 New	3,739 $224,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.